Christopher Causey United Therapeutics Corp (UTHR) insider trading activity

Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 4,190 shares of UTHR, which is worth approximately $1.95 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 1,000 shares (Common Stock) at a price of $510.0 per share, resulting in proceeds of $510,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.19K

13.87% 3M change

14.01% 12M change

Total Value Held $1.95 Million

CHRISTOPHER CAUSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2026	SELL Open market or private sale	$510,000 $510.0 p/Share	1,000 Reduced 19.27%	4,190 Common Stock
Jan 06 2026	BUY Exercise of conversion of derivative security	$119,760 $119.76 p/Share	1,000 Added 16.16%	5,190 Common Stock
Jan 02 2026	SELL Open market or private sale	$500,010 $500.01 p/Share	1,000 Reduced 19.27%	4,190 Common Stock
Jan 02 2026	BUY Exercise of conversion of derivative security	$119,760 $119.76 p/Share	1,000 Added 16.16%	5,190 Common Stock
Nov 03 2025	SELL Bona fide gift	-	450 Reduced 9.7%	4,190 Common Stock
Sep 24 2025	SELL Open market or private sale	$440,000 $440.0 p/Share	1,000 Reduced 17.05%	4,865 Common Stock
Sep 24 2025	BUY Exercise of conversion of derivative security	$119,760 $119.76 p/Share	1,000 Added 14.57%	5,865 Common Stock

Sep 02 2025	SELL Open market or private sale	$1,269,630 $423.21 p/Share	3,000 Reduced 38.14%	4,865 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$396,900 $132.3 p/Share	3,000 Added 27.61%	7,865 Common Stock
Jul 25 2025	BUY Exercise of conversion of derivative security	-	1,190 Added 19.65%	4,865 Common Stock
Nov 01 2024	SELL Open market or private sale	$192,081 $376.63 p/Share	510 Reduced 12.19%	3,675 Common Stock
Sep 09 2024	SELL Bona fide gift	-	225 Reduced 4.62%	4,640 Common Stock
Aug 21 2024	SELL Open market or private sale	$422,290 $349.0 p/Share	1,210 Reduced 22.43%	4,185 Common Stock
Aug 21 2024	BUY Exercise of conversion of derivative security	$160,083 $132.3 p/Share	1,210 Added 18.32%	5,395 Common Stock
Jun 18 2024	SELL Open market or private sale	$912,540 $304.18 p/Share	3,000 Reduced 41.75%	4,185 Common Stock
Jun 18 2024	BUY Exercise of conversion of derivative security	$336,420 $112.14 p/Share	3,000 Added 29.46%	7,185 Common Stock
Jun 13 2024	SELL Open market or private sale	$563,060 $281.53 p/Share	2,000 Reduced 32.34%	4,185 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	$224,280 $112.14 p/Share	2,000 Added 24.43%	6,185 Common Stock
May 15 2024	SELL Open market or private sale	$545,800 $272.9 p/Share	2,000 Reduced 32.34%	4,185 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$224,280 $112.14 p/Share	2,000 Added 24.43%	6,185 Common Stock
May 03 2024	SELL Open market or private sale	$582,198 $259.91 p/Share	2,240 Reduced 34.86%	4,185 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$251,193 $112.14 p/Share	2,240 Added 25.85%	6,425 Common Stock
Dec 15 2023	SELL Open market or private sale	$102,000 $255.0 p/Share	400 Reduced 8.72%	4,185 Common Stock
Dec 12 2023	SELL Open market or private sale	$749,040 $249.68 p/Share	3,000 Reduced 39.55%	4,585 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$526,290 $175.43 p/Share	3,000 Added 28.34%	7,585 Common Stock

Christopher Causey

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account